Emcure Pharmaceuticals Ltd.

Industry:

Pharmaceuticals & Drugs

Issue Details

  • Open Date

    03 Jul 2024
  • Close Date

    05 Jul 2024
  • Size (in Crs.)

    1381.32

  • Size (Shares)

    -
  • Listing On

    BSE, NSE

Issue Terms

  • Price Range

    -48
  • Lot Size

    14

  • Type

    Book building

  • Face Value

    10

  • Market Lot

    1

Objective of the Issue

1. Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by our Company; and2. General corporate purposes.

Description

We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. We were ranked as (i) the 12th largest pharmaceutical company in India and (ii) the largest pharmaceutical company in India in the gynecology, blood related and HIVantivirals therapeutic areas, based on sales in India in the Financial Year 2021, according to CRISIL. We are an R&D drivencompany with a differentiat...  Show More

Address

Plot No. P-1 & P-2 , I T - B T Park, Phase- I I , M I D C, Hinjawadi

Pune

411057

State

Maharashtra

Phone No.

020-3507003 / 35070000

Email

investors@emcure.com

Website

www.emcure.com

Promoter Holding

Promoters:

Satish Ramanlal Mehta, Sunil Rajanikant Mehta

Total Share Capital

150055468

Offered to Public

13703538

% Promoter's Holding (Pre-Issue)  

82.98

% Promoter's Holding (Post-Issue)  

78.08

Shares on offer

Total Share Offer

150055468

Of above offred to public

13703538

Post Issue shares

NA

Post Issue Promoters

78.08

Lead Managers to the Issue:

Axis Capital Ltd., Jefferies India Pvt Ltd., JP Morgan India Pvt Ltd, Kotak Mahindra Capital Co Ltd

Registrar Details

Registrar Name:

Link Intime India Pvt Ltd.

Address

C 101, 247 Park , LBS Marg , Vikhroli (West) , Mumbai

400083

Phone No.

+91 810 811 8484

Email

helpdesk@linkintime.co.in

Website

www.linkintime.co.in

Fax

91-022-49186060

Prudent Corporate Advisory Services Ltd.
"Prudent House", Panjrapole Cross Road,
Nr. Polytechnic, Ambawadi,
Ahmedabad - 380 015, Gujarat, India.
For Queries:
kyc@fundzbazar.com
1800 419 5051 (Toll Free)
Compliance Officer:
Mrs. Rima Patel
compliancemf@prudentcorporate.com
(079) 40209600
Social Media

Prudent Corporate Advisory Services Ltd.(PCAS): Member of NSE & BSE – SEBI Registration No as stock broker: INZ000293634. Member ID : - NSE : 90209, BSE : 6733, CDSL – IN-DP- 477-2020 (DP ID: 12090600), CIN - L91120GJ2003PLC042458.

Registered Address: Prudent House, Panjrapole Cross Road, Nr. Polytechnic, Ambawadi, Ahmedabad - 380015, Gujarat, India.

For any complaints pertaining to securities / broking please write a mail to ig@prudentcorporate.com

Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI

Investor Alert:
  1. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  2. Prevent Unauthorized transactions in your Trading / Demat account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange / CDSL on your mobile/email at the end of the day / same day.......... Issued in the interest of investors.
  3. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor's account.
  4. Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  5. Filing complaints on SCORES – Easy & quick
    • a. Register on SCORES portal b. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. c. Benefits: i. Effective communication. ii.Speedy redressal of the grievances.
  6. SEBI COMPLAINTS REDRESS SYSTEM Link :- https://scores.gov.in/scores/Welcome.html
  • Attention Investor:
  • 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the NSE's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 & BSE’s notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors

Company does not offer any scheme for any assured returns. In case, any such scheme offered by any of employee or other Authorized Person of the company, the same should not be accepted and no investment in such scheme to be made. In case of any such scheme offered by any person, kindly contact compliance team of the company on (+91) (79) 40209600. In case any investment made in such scheme, company will not be responsible for any claims or grievances for any loss on account of relying on the said scheme. 

Advertisement Disclosure - Non-Broking Products/Services e.g. Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc "These are not Exchange traded product and the Member is just acting as distributor and all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.”